Liraglutide Cost: Price, Insurance, and Savings Explained

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This cost breakdown is part of the PlexusDx Education Hub, where GLP-1 pricing, coverage, and the genetics behind metabolic decisions are explained in plain terms. Browse the full Peptides & GLP-1 library.

Almost nobody pays the number they first see quoted for liraglutide online. The real out-of-pocket figure is assembled from insurance design, the indication written on the prescription, savings-card eligibility, pharmacy pricing, and whether a compounded pathway applies. This article separates the published list price from what patients actually hand over at the counter, using only current figures as of April 2026.

The published list price

Liraglutide's U.S. list price sits at roughly $815 per month as of April 2026, per Novo Nordisk published pricing. Treat that number as a ceiling and a starting point rather than a real-world bill — it precedes insurance, rebates, manufacturer savings, and pharmacy negotiation. What you ultimately pay hinges on your plan, formulary tier, prior-authorization outcome, and the indication on the script.

How insurance shapes the bill

Commercial coverage of liraglutide depends on whether the prescription is written for an FDA-approved indication and on each plan's formulary and prior-authorization rules. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes; coverage for chronic weight management is far more uneven, frequently gated behind BMI-based prior authorization, and sometimes excluded outright. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though some products carry cardiovascular-indication coverage. Confirm directly with your plan.

Manufacturer savings and discount platforms

Novo Nordisk publishes a savings-card program that can meaningfully lower monthly out-of-pocket cost for eligible commercially insured patients. Eligibility generally excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and the cards carry monthly and annual caps that change over time — verify current terms on the manufacturer site at the moment of fill. Independent discount platforms such as GoodRx and SingleCare also list coupon prices that shift from pharmacy to pharmacy.

What changed with compounding

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally prepared compounded versions of those molecules. The agency resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing that window without ending all legitimate compounding activity. Compounded formulations remain available through licensed pathways where clinically justified; they are not identical to FDA-approved brand products and are priced separately.

Typical out-of-pocket scenarios

With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month, subject to plan terms and caps. When the plan does not cover the indication, cash cost lands closer to list price minus whatever coupon applies. Without insurance, cash cost approaches full list. PlexusDx offers compounded semaglutide and tirzepatide through its Weight Management Protocols, with per-protocol pricing published on each product page.

The genetics underneath the invoice

PlexusDx does not sell or prescribe liraglutide. Whatever GLP-1 pathway compound you eventually discuss, the biology is shared. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, mapping variants including FTO, MC4R that influence baseline appetite regulation and energy balance. It maps terrain rather than predicting drug response, and it is not pharmacogenomic — a way to "test before you invest" and enter the pricing conversation better informed. For a related brand-level cost view, see Victoza price.

Reading a quoted price critically

The single most useful habit when researching liraglutide cost is to ask what a quoted number actually represents. A headline figure pulled from a coupon site, a manufacturer list page, or a forum post can each describe a very different situation, and none of them may match your plan. Before assuming a price applies to you, confirm the indication your prescription would carry, check your formulary tier, and ask the pharmacy to run it with any savings card attached. Because compounded formulations follow their own separate pricing entirely, they are not a like-for-like comparison with brand list prices. Treating every quote as a scenario rather than a fixed fact keeps expectations grounded in your specific coverage.

Frequently Asked Questions

How much does liraglutide cost per month?

The U.S. list price is approximately $815 per month as of April 2026 per Novo Nordisk published pricing. Insurance, savings cards, and pharmacy discounts can substantially change the counter price, so verify the current amount with your pharmacy before filling the prescription.

Will my insurance cover it?

Coverage depends on the plan, formulary, FDA indication on the prescription, and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while weight-management coverage varies widely. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are savings cards available?

Novo Nordisk publishes a manufacturer savings-card program for eligible commercially insured patients, and independent platforms such as GoodRx list discount prices. Government-insurance enrollees are typically excluded from manufacturer cards, so check the manufacturer site for current terms and caps at the time of fill.

Are lower-cost alternatives available?

Licensed compounding pharmacies prepare compounded semaglutide and tirzepatide at separate price points — these are legally and factually distinct from brand products, not generics. PlexusDx offers both molecules through its Weight Management Protocols with pricing published on each product page.

Keep reading at the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.